Form 4/A for XTNT Xtant Medical Holdings, Inc.
Accepted 2024-02-16 00:00:00 ET · period of report 2023-10-15 · accession 0001235802-24-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-02-16 | 2023-10-15 | XTNT | Browne Sean E | Pres, CEO, Dir | F - Tax | $1.08 | -105.4K | 1.58M | -6% | -$113.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-15 | F | D | 105,442 | $1.08 | 1,575,358 | D | — | — | (F1) The purpose of this Form 4 amendment is to correct the number of shares withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards. (F2) Includes 174,216 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares to be issued upon vesting pursuant to restricted stock awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended from time to time, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates. |